Adam Friedman, MD, FAAD, of George Washington School of Medicine and Health Sciences, delivered an engaging presentation in LA reviewing hyperhidrosis, noting that up to 10 million individuals in the U.S. are affected by the condition. Hyperhidrosis can be defined as the excessive, bilateral and generally symmetrical sweating at abnormal levels unprompted by activity or …
Dr. Joslyn Kirby kicked off the SDPA Digital CME conference Thursday morning with an enlightening review of the dermatology medical literature published within the last year. Dr. Kirby initiated the presentation by illustrating the dermatologic manifestations of COVID-19 with an important reminder that these cutaneous presentations are “not pathognomonic to COVID.” Additionally, she reviewed the …
Biologic treatments have been used to target aberrant immune responses in many diseases including the dermatologic manifestations of psoriasis, systemic lupus erythematosus and atopic dermatitis. The use of biologics is not without hazard as these agents block immune pathways adapted to protect the host. For medical providers who prescribe these agents, there has been concern …
Systemic sclerosis is a rare chronic disease of unknown cause characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. The term scleroderma, is used to describe the presence of thickened, hardened skin and can be the first diagnostic feature of systemic sclerosis (Ssc). Systemic sclerosis is classified based on the …
The first cases of Coronavirus disease, also known as COVID-19, presented in China in December of 2019. Clinical signs of COVID include dry cough, fever, shortness of breath, fatigue, loss of taste, loss of smell, loss of appetite and rhinorrhea. Due to the extraordinary need of medical providers in Italy, dermatologists found themselves along the …